Copyright
©The Author(s) 2017.
World J Diabetes. May 15, 2017; 8(5): 172-186
Published online May 15, 2017. doi: 10.4239/wjd.v8.i5.172
Published online May 15, 2017. doi: 10.4239/wjd.v8.i5.172
Figure 1 Renal outcomes in the trial Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome.
1Four-point renal outcome = progression to macroalbuminuria, doubling of serum creatinine, initiation of RRT or death from renal disease; 2Macroalbuminuria = albumin to creatinine ratio > 30 mg/mmol; 3Plus eGFR < 45 mL/min per 1.73 m2. eGFR: Estimated glomerular filtration rate; HR: Hazard ratio; NS: Non statistically significant; RRT: Renal replacement therapy.
- Citation: MacIsaac RJ, Jerums G, Ekinci EI. Effects of glycaemic management on diabetic kidney disease. World J Diabetes 2017; 8(5): 172-186
- URL: https://www.wjgnet.com/1948-9358/full/v8/i5/172.htm
- DOI: https://dx.doi.org/10.4239/wjd.v8.i5.172